Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.
Clinical trial NCT04450004 · COMPLETED
Trial details
- NCT number
- NCT04450004
- Sponsor
- Medicago
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2020-09-20
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.